KADCYLA TRASTUZUMAB EMTANSINE

Welcome to the Brand page for “KADCYLA TRASTUZUMAB EMTANSINE”, which is offered here for Providing educational training in the medical field;the mark consists of a y with a semi-circle above it next to the word kadcyla trastuzumab emtansine.;pharmaceutical preparations containing trastuzumab emtansine for treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, inflammatory diseases and disorders, gastro-intestinal diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, infectious diseases and disorders, metabolic diseases and disorders;color is not claimed as a feature of the mark.;medical services;trastuzumab emtansine;.

Its status is currently believed to be active. Its class is unavailable. “KADCYLA TRASTUZUMAB EMTANSINE” is believed to be currently owned by “GENENTECH, INC.”